TAYLOR BEN R (Chief Financial Officer) reported 1 transaction at RECURSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/26/2025ACC: 0001712276-25-000013
Officer· Chief Financial Officer
Since Feb 2026
-2.27K
Net shares
Net seller
$9.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
2.27K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−2.27K
Price / share
$4.03
Trade value
$9.15K
% of position
0.3%
11/25/2025
792.26K→789.99K
Total
Net shares
−2.27K
Net value
-$9.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 11/25/2025 | F · Tax Withholding | −2.27K | $4.03 | $9.15K | 0.3% | 792.26K | 789.99K |
| Total | −2.27K | -$9.15K | ||||||
Derivative Transactions0
No derivative transactions reported